Company Grants License to Its Diabetes Biomarkers
Intrinsic Bioprobes, of Tempe, Ariz.,a privately held biotechnology company, has licensed two novel biomarkers for diabetes to Ortho-Clinical Diagnostics, Inc., of Raritan, N.J.
Diagnosis & Disease Information
Gambro Acquires Medical Device Company
Gambro, which has its U.S. headquarters in Lakewood, Colo., has acquired CHF Solutions, a privately held medical device company in Brooklyn Park, Minn., that manufactures and distributes ultrafiltration devices to treat fluid overload, both companies announced recently.
Fresenius Buys the Company That Sells Acumen nEHR
Fresenius Medical Care North America (FMCNA), headquartered in Waltham, Mass., has acquired Nashville-based Health IT Services Group and its portfolio of products, including Acumen nEHR, a nephrology-specific electronic health record.
Drug Cleared for Treating Moderate to Severe Rheumatoid Arthritis
Roche has received marketing clearance for Actemra (tocilizumab) as a treatment for moderate to severe active rheumatoid arthritis (RA) in adults who have had an inadequate response to one or more treatments that block tumor necrosis factor.
FDA Warns Consumers about Counterfeit Weight-Loss Product
The FDA has issued a warning to consumers about a counterfeit and possibly harmful version of Alli 60 mg capsules (120 count refill kit). Alli is an over-the-counter weight-loss product.
Wyeth Makes Drug Monitoring Changes for Sirolimus
Wyeth has notified health care professionals of changes to the Rapamune (sirolimus) prescribing information related to changes in the performance of an immunoassay used for therapeutic drug monitoring (TDM) of the medication, according to the FDA.
Companies with Unique Advantages are Resilient in Downturns
Warren Buffett has often talked about investing in companies that are protected by “wide moats.” Such businesses dominate their markets for years because of advantages that competitors cannot duplicate.
Brachytherapy Very Effective Long-Term
Brachytherapy offers excellent oncologic outcomes and is associated with a low rate of adverse events, data show.
Excellent Short-Term Outcomes Reported for Robot-Assisted Partial Nephrectomy
Robot-assisted partial nephrectomy (RAPN) is a safe and effective approach for nephron-sparing surgery (NSS) that is capable of providing patients with excellent short-term oncologic outcomes, according to the largest RAPN experience described to date.
Expanding the Kidney Donor Pool
Strategies include the use of non-standard-criteria kidney donation and kidney-exchange programs.
- Loading...
Loading...
Loading... 
Loading...